Accurate and Precise Quantitation of the Pentadecapeptide BPC-157 from Human Plasma by HPLC-MS/MS

Chad Christianson1, Tara O’Brien1 and Jennifer Zimmer1
1Alturas Analytics, Inc, Moscow, Idaho

Introduction
BPC-157 is a pentadecapeptide gastric peptide that possesses free radical scavenging activity and has been shown to reduce inflammation by blocking the production of proinflammatory mediators (nitric oxide, prostaglandins, and leukotrienes). The data suggests that BPC-157 promotes proliferation, migration and tube formation of human umbilical vein endothelial cells through activation of ERK1/2 phosphorylation and is effective without a carrier. BPC-157 increases the production of hepatocyte growth factors (HGFs), which stimulate cell proliferation and promote tissue repair by upregulating the genes involved in wound healing. BPC-157 has been shown to have healing properties for gastrointestinal fistulas, intestinal lesions, liver lesions and can be used for the treatment of inflammatory bowel disease and congestive heart failure. BPC-157 has also been shown to accelerate the healing of damaged tendons and ligaments. In order to accurately quantify the peptide in plasma an extraction and HPLC-MS/MS method was developed with a linear range of 0.100-1000 ng/mL.

Methods
A precipitation extraction followed by HPLC-MS/MS analysis was developed for the quantitative analysis of BPC-157 in plasma. Human plasma was spiked with the peptide and the mixture was extracted using a methanol/acetonitrile precipitation. The supernatant was dried and then reconstituted with 100 μL water/acetonitrile containing 0.1% formic acid 4/1 . The sample was then analyzed by HPLC-MS/MS on an API-6500+ (Sciex) mass spectrometer operating in positive ESI mode. Separation was achieved using an Agilent Pursuit Diphenyl column (10 cm x 2.1 mm, 5 μm). Mobile phase A consisted of water with 0.1% formic acid. Mobile phase B was prepared in acetonitrile containing 0.1% formic acid.

Results
The data indicates that with a simple precipitation extraction and HPLC-MS/MS analysis BPC-157 can be accurately and precisely quantified from human plasma. A linear calibration curve can be generated from 0.100 to 1000 ng/mL.

Conclusions
A simple extraction and HPLC-MS/MS method has been developed to accurately and precisely quantify BPC-157 from human plasma.

About the Presenter

Chad leads a team of scientists as Study Director and Principal Investigator, providing technical oversight to clients across all therapeutic areas. In addition, he heads research at Alturas with a focus on investigating and applying novel technologies to the bioanalytical challenges of our evolving industry.

Please complete the form below in order to access our resource:

"*" indicates required fields